Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alkaline Phosphatase, Placental Type (PLAP) is a membrane-bound, glycosylated dimeric enzyme primarily expressed in the placenta. It functions as a metalloenzyme catalyzing the hydrolysis of phosphoric acid monoesters. While its exact physiological role is under investigation, it is significantly elevated in several cancers, including testicular germ cell tumors, ovarian cancer, and uterine corpus endometrial carcinoma, making it a useful tumor marker and potential immunotherapy target.
Hydrolyzes phosphoric acid monoesters. Immunotherapy targeting is being investigated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alkaline Phosphatase, Placental Type (PLAP).